In­tel­lia Ther­a­peu­tics cuts 15% of work­force, ex­tends cash run­way in­to mid-2026

In­tel­lia Ther­a­peu­tics an­nounced Thurs­day that it is cut­ting 15% of its work­force and paus­ing cer­tain re­search pro­grams fol­low­ing an in­ter­nal re­view.

A rep­re­sen­ta­tive for In­tel­lia told End­points News that the com­pa­ny cut po­si­tions across all de­part­ments, though it won’t im­pact its lead pro­grams and can­di­dates. The pro­grams that In­tel­lia is end­ing “would gen­er­al­ly be undis­closed tar­gets/projects that were much ear­li­er in the re­search process,” ac­cord­ing to the rep­re­sen­ta­tive.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.